Ameritas Investment Partners’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.05M | Sell |
37,235
-263
| -0.7% | -$14.5K | 0.06% | 328 |
|
|
2025
Q1 | $2.65M | Sell |
37,498
-675
| -2% | -$47.7K | 0.09% | 218 |
|
|
2024
Q4 | $2.51M | Sell |
38,173
-886
| -2% | -$58.2K | 0.08% | 250 |
|
|
2024
Q3 | $2.75M | Sell |
39,059
-1,328
| -3% | -$93.3K | 0.09% | 228 |
|
|
2024
Q2 | $3.33M | Buy |
+40,387
| New | +$3.33M | 0.11% | 155 |
|
|
2020
Q4 | – | Sell |
-3,463
| Closed | -$263K | – | 3072 |
|
|
2020
Q3 | $263K | Sell |
3,463
-117
| -3% | -$8.89K | 0.01% | 909 |
|
|
2020
Q2 | $442K | Hold |
3,580
| – | – | 0.02% | 736 |
|
|
2020
Q1 | $303K | Hold |
3,580
| – | – | 0.02% | 781 |
|
|
2019
Q4 | $303K | Buy |
3,580
+222
| +7% | +$18.8K | 0.01% | 884 |
|
|
2019
Q3 | $226K | Hold |
3,358
| – | – | 0.01% | 986 |
|
|
2019
Q2 | $288K | Buy |
3,358
+93
| +3% | +$7.98K | 0.01% | 887 |
|
|
2019
Q1 | $290K | Hold |
3,265
| – | – | 0.01% | 875 |
|
|
2018
Q4 | $278K | Buy |
3,265
+146
| +5% | +$12.4K | 0.02% | 836 |
|
|
2018
Q3 | $302K | Sell |
3,119
-7
| -0.2% | -$678 | 0.01% | 877 |
|
|
2018
Q2 | $294K | Hold |
3,126
| – | – | 0.01% | 873 |
|
|
2018
Q1 | $253K | Hold |
3,126
| – | – | 0.01% | 966 |
|
|
2017
Q4 | $279K | Hold |
3,126
| – | – | 0.01% | 918 |
|
|
2017
Q3 | $281K | Hold |
3,126
| – | – | 0.01% | 903 |
|
|
2017
Q2 | $284K | Buy |
3,126
+54
| +2% | +$4.91K | 0.01% | 897 |
|
|
2017
Q1 | $270K | Hold |
3,072
| – | – | 0.01% | 919 |
|
|
2016
Q4 | $254K | Hold |
3,072
| – | – | 0.01% | 926 |
|
|
2016
Q3 | $284K | Buy |
3,072
+207
| +7% | +$19.1K | 0.02% | 876 |
|
|
2016
Q2 | $223K | Buy |
2,865
+152
| +6% | +$11.8K | 0.01% | 906 |
|
|
2016
Q1 | $224K | Hold |
2,713
| – | – | 0.01% | 908 |
|
|
2015
Q4 | $284K | Buy |
2,713
+68
| +3% | +$7.12K | 0.02% | 819 |
|
|
2015
Q3 | $279K | Buy |
+2,645
| New | +$279K | 0.02% | 796 |
|